4Murakami K,Takemura T,Hino S, et al. Urinary transforming growth factor in patients with glomerular disease[ J]. Pediatr Nephrol, 1997,11 (3) :334～336.
5Senatorski G,Paczek L,Sulowiez W, et al. Urine activity of cathepsin B, collagenase and urine excretion of TGFβ1 and fibronectln in membranous glomerulonephritls[J]. Res Exp Med, 1998,198(4) : 199～206.
3Vazquez MA. Chronic rejection of renal transplants: new clinical insights [J] .Am J Med Sci,2000,3.20(1) :43 -58.
4Abdel WN, Weston BS, Roberts T, et al. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy [J] .J Am Soc Nephrol,2002,13(14) :2437 ~ ?2445.
5Amann K, Koch Ahofstetter J. Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers [ J ]. Kidney Int. 2004,63(11) : 1309 ~ 1323.
6lshii H,Tada H,lsogai S. An aldose reductase inhibitor prevents glucose- induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial cells[ J ]. Diabetologia, 1998,41 (2) : 362 ~ 364.
7Woo YC, Jong AH, Young KW. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy [ J ]. Transplantation ,2003,75(2) :309 ~ 315.
8Morales JM, Andres A, Rengel M, et al. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation [ J ]. Nephrel Dial Transplant, 2003, 18 ( 1 ) : 119 -121.
9Ishimura T, Fujisawa M, Higuchi A, et al. Transforming growth factor-beta 1 expression in early biopsy specimen predicts long-term graft function following pediatric renal transplantation [ J]. Clin Transplant, 2001,15 ( 2 ) : 185- 191.
10Citterlo F, Pozzetto U, Romagnoli J, et al. Plasma levels of transforming growth factor-β1 in renal transplant recipients receiving different immunosuppressive regimens [ J ]. Transplantation Proceedings, 2004, 36 (4) :698 - 699.
